KRP-105
KRP-105 is a potent, highly selective, and orally effective PPAR alpha (EC50 = 8 nM) agonist. KRP-105 can significantly reduce serum triglyceride, total cholesterol, and non high density lipoprotein cholesterol levels. KRP-105 can be used for research on metabolic diseases such as dyslipidemia.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 876145-69-6
- 分子式: C23H22ClN3O3S
- 分子量:455.96
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
製品説明
IC50 & Target
[1]|
PPARα |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| CHO-K1 | EC50 |
0.008 μM
Compound: (S)-4f, KRP-105
|
Transactivation of human PPARalpha expressed in CHO-K1 cells
Transactivation of human PPARalpha expressed in CHO-K1 cells
|
[PMID: 22133631] |
| CHO-K1 | EC50 |
3 μM
Compound: (S)-4f, KRP-105
|
Transactivation of human PPARdelta expressed in CHO-K1 cells
Transactivation of human PPARdelta expressed in CHO-K1 cells
|
[PMID: 22133631] |
| CHO-K1 | EC50 |
9.6 μM
Compound: (S)-4f, KRP-105
|
Transactivation of human PPARgamma expressed in CHO-K1 cells
Transactivation of human PPARgamma expressed in CHO-K1 cells
|
[PMID: 22133631] |
| HEK-293T | EC50 |
5 nM
Compound: SC-1
|
Agonist activity at GAL4-tagged PPARalpha ligand-binding domain (unknown origin) expressed in HEK293T cells incubated for 16 to 19 hrs by beta-lactamase reporter gene assay
Agonist activity at GAL4-tagged PPARalpha ligand-binding domain (unknown origin) expressed in HEK293T cells incubated for 16 to 19 hrs by beta-lactamase reporter gene assay
|
[PMID: 25491112] |
化学情報
-
CAS 番号 876145-69-6
-
分子量 455.96
-
分子式 C23H22ClN3O3S
-
SMILES
OC(C1=CC=CC(N(CCC2)C[C@H]2NC(C3=C(C)N=C(C4=CC=C(C=C4)Cl)S3)=O)=C1)=O
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)